In today’s recent session, 10.29 million shares of the Quince Therapeutics Inc (NASDAQ:QNCX) have been traded, and its beta is 0.86. Most recently the company’s share price was $1.35, and it changed around $0.17 or 14.40% from the last close, which brings the market valuation of the company to $58.42M. QNCX at last check was trading at a discount to its 52-week high of $1.43, offering almost -5.93% off that amount. The share price’s 52-week low was $0.51, which indicates that the recent value has risen by an impressive 62.22% since then. We note from Quince Therapeutics Inc’s average daily trading volume that its 10-day average is 0.97 million shares, with the 3-month average coming to 297.36K.
Quince Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended QNCX as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Quince Therapeutics Inc is expected to report earnings per share of -0.1 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Quince Therapeutics Inc (NASDAQ:QNCX) trade information
Instantly QNCX has been showing a green trend so far today with a performance of 14.40% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.7900 on recent trading dayincreased the stock’s daily price by 24.58%. The company’s shares are currently up 28.56% year-to-date, but still up 55.16% over the last five days. On the other hand, Quince Therapeutics Inc (NASDAQ:QNCX) is 74.18% up in the 30-day period. We can see from the shorts that 1.91 million shares have been sold at a short interest cover period of 30.08 day(s).
QNCX Dividends
Quince Therapeutics Inc’s next quarterly earnings report is expected to be released on 2024-Nov-12.
Quince Therapeutics Inc (NASDAQ:QNCX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 13.74% of Quince Therapeutics Inc shares, and 25.24% of them are in the hands of institutional investors. The stock currently has a share float of 29.27%.
